Literature DB >> 20211562

166th ENMC International Workshop on Collagen type VI-related Myopathies, 22-24 May 2009, Naarden, The Netherlands.

Valérie Allamand1, Luciano Merlini, Kate Bushby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20211562     DOI： 10.1016/j.nmd.2010.02.012

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  12 in total

Review 1.  The collagen VI-related myopathies: muscle meets its matrix.

Authors:  Carsten G Bönnemann
Journal:  Nat Rev Neurol       Date:  2011-06-21       Impact factor: 42.937

2.  Novel collagen VI mutations identified in Chinese patients with Ullrich congenital muscular dystrophy.

Authors:  Yan-Zhi Zhang; Dan-Hua Zhao; Hai-Po Yang; Ai-Jie Liu; Xing-Zhi Chang; Dao-Jun Hong; Carsten Bonnemann; Yun Yuan; Xi-Ru Wu; Hui Xiong
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

3.  COL6A3 protein deficiency in mice leads to muscle and tendon defects similar to human collagen VI congenital muscular dystrophy.

Authors:  Te-Cheng Pan; Rui-Zhu Zhang; Dessislava Markova; Machiko Arita; Yejia Zhang; Sasha Bogdanovich; Tejvir S Khurana; Carsten G Bönnemann; David E Birk; Mon-Li Chu
Journal:  J Biol Chem       Date:  2013-04-05       Impact factor: 5.157

4.  ColVI myopathies: where do we stand, where do we go?

Authors:  Valérie Allamand; Laura Briñas; Pascale Richard; Tanya Stojkovic; Susana Quijano-Roy; Gisèle Bonne
Journal:  Skelet Muscle       Date:  2011-09-23       Impact factor: 4.912

5.  Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results.

Authors:  Luciano Merlini; Patrizia Sabatelli; Annarita Armaroli; Saverio Gnudi; Alessia Angelin; Paolo Grumati; Maria Elena Michelini; Andrea Franchella; Francesca Gualandi; Enrico Bertini; Nadir Mario Maraldi; Alessandra Ferlini; Paolo Bonaldo; Paolo Bernardi
Journal:  Oxid Med Cell Longev       Date:  2011-10-17       Impact factor: 6.543

6.  Nutritional status evaluation in patients affected by bethlem myopathy and ullrich congenital muscular dystrophy.

Authors:  Silvia Toni; Riccardo Morandi; Marcello Busacchi; Lucia Tardini; Luciano Merlini; Nino Carlo Battistini; Massimo Pellegrini
Journal:  Front Aging Neurosci       Date:  2014-11-17       Impact factor: 5.750

7.  Col6a1 null mice as a model to study skin phenotypes in patients with collagen VI related myopathies: expression of classical and novel collagen VI variants during wound healing.

Authors:  Sandra Lettmann; Wilhelm Bloch; Tobias Maaß; Anja Niehoff; Jan-Niklas Schulz; Beate Eckes; Sabine A Eming; Paolo Bonaldo; Mats Paulsson; Raimund Wagener
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

8.  Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy.

Authors:  Francesca Gualandi; Elisa Manzati; Patrizia Sabatelli; Chiara Passarelli; Matteo Bovolenta; Camilla Pellegrini; Daniela Perrone; Stefano Squarzoni; Elena Pegoraro; Paolo Bonaldo; Alessandra Ferlini
Journal:  Hum Gene Ther       Date:  2012-11-06       Impact factor: 5.695

9.  Natural history of pulmonary function in collagen VI-related myopathies.

Authors:  A Reghan Foley; Susana Quijano-Roy; James Collins; Volker Straub; Michelle McCallum; Nicolas Deconinck; Eugenio Mercuri; Marika Pane; Adele D'Amico; Enrico Bertini; Kathryn North; Monique M Ryan; Pascale Richard; Valérie Allamand; Debbie Hicks; Shireen Lamandé; Ying Hu; Francesca Gualandi; Sungyoung Auh; Francesco Muntoni; Carsten G Bönnemann
Journal:  Brain       Date:  2013-11-22       Impact factor: 13.501

10.  Body composition, muscle strength, and physical function of patients with Bethlem myopathy and Ullrich congenital muscular dystrophy.

Authors:  Maria Teresa Miscione; Francesca Bruno; Claudio Ripamonti; Giuliana Nervuti; Riccardo Orsini; Cesare Faldini; Massimo Pellegrini; Daniela Cocchi; Luciano Merlini
Journal:  ScientificWorldJournal       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.